Article
Study of MiR-451 in the Treatment of Human Gliomas through Regulating the AMPK Pathway Mediated by Bone Mesenchymal Stem Cells
2021-06-18
Abstract excerpt
Accumulating evidence has suggested that gene therapy plays critical roles in glioma treatment. Our previous studies demonstrated that miR-451 could be used as a tumor suppressor via targeting CAB39. But the ability for the targeted delivery of miR-451 to glioma was a significant issue. Bone marrow mesenchymal stem cells (BMSCs) have been used for systemic delivery of therapeutic genes to solid tumors. In the pres...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 83453007-450a-5958-a22a-dab2e27202c2
- DOI
- 10.21203/rs.3.rs-604846/v1
